Strategies for the Total Synthesis of Fucoxanthin from a Commercial Perspective
SynOpen · 01.10.2024 · 08 (04) · 259-264
DOI: 10.1055/a-2423-9269 ↗Kurz gefasst
Fachartikel in der Zeitschrift SynOpen, erschienen am 01.10.2024. Verfasst von Sayan Dutta Gupta und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Evaluation Institute of Industrial Technology, Korea Institute of Marine Science and Technology Promotion.
Abstract (Originalsprache)
Fucoxanthin, the light-harvesting pigment of various algae, has shown promising biological activity in pre-clinical and clinical models. It has also received marketing approval as a nutraceutical and cosmetic ingredient in the USA and other countries. The commercial synthesis of this natural ingredient assumes significance because of various drawbacks (low yield, patent infringement, longer duration of cultivation, etc.) associated with its extraction and isolation procedures. This review is intended to provide an appraisal of the total syntheses of fucoxanthin reported to date along with a detailed explanation of the commercially viable approach. Finally, we briefly discuss the future of research for the total synthesis of fucoxanthin.
Förderung
- Korea Evaluation Institute of Industrial Technology
- Korea Institute of Marine Science and Technology Promotion
Zitieren
APA
Gupta, S. D., & Pan, C. (2024). Strategies for the Total Synthesis of Fucoxanthin from a Commercial Perspective. SynOpen, 08(04), 259-264. https://doi.org/10.1055/a-2423-9269
Vancouver
Gupta SD, Pan C. Strategies for the Total Synthesis of Fucoxanthin from a Commercial Perspective. SynOpen. 2024;08(04):259-264. doi:10.1055/a-2423-9269
BibTeX
@article{Gupta2024,
author = {Gupta, Sayan Dutta and Pan, Cheol-Ho},
title = {Strategies for the Total Synthesis of Fucoxanthin from a Commercial Perspective},
journal = {SynOpen},
year = {2024},
volume = {08},
number = {04},
pages = {259--264},
doi = {10.1055/a-2423-9269}
}
EUVIMED